Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -13.34 | 13.49 |
PEG Ratio (TTM) | 0.26 | 6.38 |
P/S Ratio (TTM) | 1.18 | 6.72 |
P/B Ratio (TTM) | 1.50 | 30.82 |
P/FCF Ratio (TTM) | -32.40 | 14.74 |
Price to 5YR AVG Earnings Ratio | -5.98 | 3.65 |
Price to 5YR AVG FCF Ratio | -564.43 | 47.45 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.61% | 0.10% |
ROE (TTM) | -11.45% | -133.72% |
Net Profit Margin (TTM) | -8.50% | 1.11% |
ROIC 5YR AVG | -13.67% | 28.40% |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -236.75% | 47.04% | 38.77% |
Revenue | 0.40% | 130.74% | 89.52% |
Net Income | -244.55% | 13.53% | 16.88% |
Cash Flow | 107.79% | 2,321.88% | 2,393.63% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.05 | 2.61 |
Quick Ratio (TTM) | 1.05 | 2.48 |
D/E Ratio (TTM) | 0.14 | 1.12 |
Interest Coverage (TTM) | -1.81 | 5.87 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 1.81 | 4.65 |
LTL to 5YR AVG FCF | -12.00 | 3.23 |
Shares Outstanding Growth 5YR AVG | 65.30% | 2.01% |